相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Thrombopoietin levels in patients with disorders of platelet production: Diagnostic potential and utility in predicting response to TPO Receptor agonists
Robert S. Makar et al.
AMERICAN JOURNAL OF HEMATOLOGY (2013)
Safety and efficacy of eltrombopag for treatment of chronic immune thrombocytopenia: results of the long-term, open-label EXTEND study
Mansoor N. Saleh et al.
BLOOD (2013)
Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy
David J. Kuter et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
The biology of thrombopoietin and thrombopoietin receptor agonists
David J. Kuter
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care
David J. Kuter et al.
AMERICAN JOURNAL OF HEMATOLOGY (2012)
Eltrombopag before Procedures in Patients with Cirrhosis and Thrombocytopenia
Nezam H. Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Eltrombopag and Improved Hematopoiesis in Refractory Aplastic Anemia
Matthew J. Olnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
The development of romiplostim for patients with immune thrombocytopenia
Graham Molineux
PHARMACEUTICAL SCIENCE TO IMPROVE THE HUMAN CONDITION: WINNERS AND FINALIST CANDIDATES OF THE PRIX GALIEN USA, INTERNATIONAL, AND PRO BONO HUMANITARIAN AWARDS 2010 (2011)
A randomized, double-blind study of romiplostim to determine its safety and efficacy in children with immune thrombocytopenia
James B. Bussel et al.
BLOOD (2011)
Significance of Thrombocytopenia in Myelodysplastic Syndromes: Associations and Prognostic Implications
Ali Al Ameri et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
Eltrombopag for management of chronic immune thrombocytopenia (RAISE): a 6-month, randomised, phase 3 study
Gregory Cheng et al.
LANCET (2011)
Eltrombopag for the treatment of the inherited thrombocytopenia deriving from MYH9 mutations
Alessandro Pecci et al.
BLOOD (2010)
Romiplostim or Standard of Care in Patients with Immune Thrombocytopenia.
David J. Kuter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Thrombocytopenia in Patients With Myelodysplastic Syndromes
Jeffrey Bryan et al.
SEMINARS IN HEMATOLOGY (2010)
Thrombopoietin and Thrombopoietin Mimetics in the Treatment of Thrombocytopenia
David J. Kuter
ANNUAL REVIEW OF MEDICINE (2009)
Eltrombopag for thrombocytopenia in patients with cirrhosis associated with hepatitis C
John G. McHutchison et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The incidence and impact of thrombocytopenia in myelodysplastic syndromes
Hagop Kantarjian et al.
CANCER (2007)
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP
James B. Bussel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A rationally designed agonist antibody fragment that functionally mimics thrombopoietin
Shana Frederickson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Max Schultze (1865), G. Bizzozero (1882) and the discovery of the platelet
DB Brewer
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist
CL Erickson-Miller et al.
EXPERIMENTAL HEMATOLOGY (2005)
Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP
R McMillan et al.
BLOOD (2004)
AMG531 stimulates megakaryopoiesis in vitro by binding to Mp1
VC Broudy et al.
CYTOKINE (2004)
Long-term administration of pegylated recombinant human megakaryocyte growth and development factor dramatically improved cytopenias in a patient with myelodysplastic syndrome
M Kizaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Recombinant human thrombopoietin: basic biology and evaluation of clinical studies
DJ Kuter et al.
BLOOD (2002)
Effects of pegylated recombinant human megakaryocyte growth and development factor in patients with idiopathic thrombocytopenic purpura
S Nomura et al.
BLOOD (2002)
Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study
S Vadhan-Raj et al.
LANCET (2002)
Thrombocytopenia caused by the development of antibodies to thrombopoietin
JZ Li et al.
BLOOD (2001)
Cyclic immune thrombocytopenia responsive to thrombopoietic growth factor therapy
L Rice et al.
AMERICAN JOURNAL OF HEMATOLOGY (2001)
Thrombopoietin therapy increases platelet yields in healthy platelet donors
DJ Kuter et al.
BLOOD (2001)
Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin
LT Goodnough et al.
BLOOD (2001)
Serum granulocyte colony-stimulating factor levels are not increased in patients with autoimmune neutropenia of infancy
S Corbacioglu et al.
JOURNAL OF PEDIATRICS (2000)
Recombinant human thrombopoietin attenuates carboplatin-induced severe thrombocytopenia and the need for platelet transfusions in patients with gynecologic cancer
S Vadhan-Raj et al.
ANNALS OF INTERNAL MEDICINE (2000)
分享论文
